Science Explorer Back to mapMap
Discussion
Researcher · Mylan (United States) · United States

Eduardo J. Pennella

Eduardo J. Pennella publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Biosimilars and Bioanalytical Methods, Lung Cancer Treatments and Mutations and HER2/EGFR in Cancer Research.

ORCID 0000-0002-1697-9220 OpenAlex
World rank
#4,330,617
of 7,710,434 ranked researchers
Rank in United States
#1,161,951
of 1,627,098
Works
48
Citations
922
Citations per work
19.2
h-index
12
i10-index 13Top 48% in Oncology
Eduardo J. Pennella

What does Eduardo J. Pennella research?

Eduardo J. Pennella's work is mostly in Medicine (69%), Immunology and Microbiology (14%).

Health Sciences: 33 works · 68.6% of their workMedicine: 33 works · 68.6% of their workOncology: 13 works · 27.1% of their workPulmonary and Respiratory Medicine: 11 works · 23.6% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 8.6% of their workSurgery: 2 works · 5.0% of their workEpidemiology: 2 works · 4.3% of their workEverything else: 8 works · 17.1% of their workLife Sciences: 7 works · 14.3% of their workImmunology and Microbiology: 7 works · 14.3% of their workImmunology: 7 works · 14.3% of their workTHEIR WORKEduardo J.Pennella48works
Life Sciences14%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3368.6%
  2. Everything else817.1%
    1. Immunology and Microbiology714.3%
  1. 1Oncology27% of their works
  2. 2Pulmonary and Respiratory Medicine24% of their works
  3. 3Immunology14% of their works
  4. 4Radiology, Nuclear Medicine and Imaging9% of their works
  5. 5Surgery5% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Eduardo J. Pennella's research?

The keywords of their largest research topics: Chemotherapy, Monoclonal Antibodies, Clinical Trials, Targeted Therapy, Biosimilars, Immunogenicity, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy364 topics
  2. Monoclonal Antibodies282 topics
  3. Clinical Trials252 topics
  4. Targeted Therapy252 topics
  5. Biosimilars191 topic
  6. Immunogenicity191 topic
  7. ALK Inhibitors161 topic
  8. EGFR Mutations161 topic
  9. Breast Cancer141 topic
  10. HER2141 topic
  11. Fc Receptors91 topic
  12. Genomic Profiles91 topic
  13. Small-Cell Lung Cancer91 topic
  14. Therapeutic Antibodies91 topic
  15. CT Screening71 topic
  16. Lung Cancer71 topic
  17. Antimicrobial Agents61 topic
  18. Febrile Neutropenia61 topic
  19. Multiple Primary Cancers51 topic
  20. Second Primary Neoplasms51 topic

Where does Eduardo J. Pennella work?

Eduardo J. Pennella's main affiliation in the publication record is Mylan (United States), United States.

How many publications and citations does Eduardo J. Pennella have?

OpenAlex counts 48 works and 922 citations for Eduardo J. Pennella, an h-index of 12, ranking #4,330,617 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Eduardo J. Pennella. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.